Replies to post #129852 on Biotech Values

[DewDiligence]

MNTA 2012-2013 News Flow

[Updates re Lovenox.]


Lovenox

• Late 2011/early 2012: Ruling by appellate court on Amphastar’s Motion to rescind preliminary injunction.

• 4-Feb-2013: Start of NVS/MNTA’s patent-infringement lawsuit against Teva. (The trial date could be accelerated if this case were consolidated with MNTA’s suit against Amphastar.)


Copaxone

• Late 2011/early 2012: Court ruling on Copaxone patent trial.

• Timing uncertain: FDA action on Copaxone ANDA.


Other programs

• Timing uncertain: Announcements regarding MNTA’s FoB programs.

• 1Q12: IND filing for M402, MNTA’s proprietary heparin-based cancer drug, followed by the start of a phase-1 trial.